$DRUG Income Statement | Understand Stock

Login

Understand Stock

Sign in or create a free account to unlock 10 years of data, build your watchlist, create alerts and more.

Sign in

$DRUG

$74.48 +$0.06 (0.08%)

Deep Research with AI Research

Overview

$DRUG Overview Financials SEC Filings Executives News

Specialized Tools

Valuations P Insider Transactions P Congressional Trades P

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Income Statement

Concept	2025	2024	2021
Revenue	$0.00 N/A	$0.00 N/A	$0.00 N/A
Cost Of Revenue	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A
Selling, General & Admin	$2.740M 75.61% YoY	$1.561M -31.98% YoY	$2.472M 778.98% YoY
Research & Development	$11.08M 839.36% YoY	1.180M cads -76.4% YoY	$6.314M 3162.2% YoY
Depreciation & Amortization	$76.90K 4.77% YoY	$73.40K 1.31% YoY	N/A
Operating Expenses	$13.90M 1078.1% YoY	1.180M cads -76.4% YoY	$8.805M 1732.89% YoY
Operating Profit	N/A	N/A	N/A
Interest Expense	$1.672M 13953.78% YoY	$11.90K -314.03% YoY	$154.1K N/A
Other Income/Expense, Net	N/A	N/A	N/A
Pretax Income	-$12.23M 336.45% YoY	-$2.802M -61.99% YoY	-$8.651M 1700.82% YoY
Income Tax	N/A	N/A	N/A
Net Earnings	-$12.23M 336.46% YoY	-2.802M cads -61.99% YoY	-$8.651M 1700.82% YoY
Basic Earnings Per Share	N/A	N/A	N/A
Diluted Earnings Per Share	-$1.78 173.82% YoY	-$0.65 -67.2% YoY	-$964.0K 1184.99% YoY
COMMON SHARES	N/A	N/A	N/A
Basic Shares Outstanding	N/A	N/A	N/A
Diluted Shares Outstanding	N/A	N/A	N/A

Concept	2025 Q4	2025 Q3	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4
Revenue	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A
Cost Of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Admin	$1.217M 120.77% YoY	$856.0K 142.08% YoY	$580.1K 85.51% YoY	$752.9K 74.02% YoY	$551.3K 21.86% YoY	$353.6K -27.96% YoY	$312.7K -20.42% YoY	$432.6K -33.48% YoY	$452.4K -45.66% YoY	$490.8K 6.29% YoY	$392.9K -35.72% YoY	$650.4K -11.4% YoY	$832.6K -14.94% YoY	$461.8K -39.12% YoY	$611.3K -34.93% YoY	$734.1K 20.64% YoY	$978.8K 183.91% YoY
Research & Development	$5.661M 441.49% YoY	$4.784M 1049.77% YoY	$2.692M 625.19% YoY	$2.563M 498.2% YoY	$1.045M -14.7% YoY	$416.1K -61.87% YoY	$371.2K -64.67% YoY	$428.5K -69.36% YoY	$1.226M -16.04% YoY	$1.091M -57.05% YoY	$1.051M -48.78% YoY	$1.398M -62.65% YoY	$1.460M -62.04% YoY	$2.541M 15.08% YoY	$2.051M -24.25% YoY	$3.743M 295.54% YoY	$3.845M 1311.07% YoY
Depreciation & Amortization	$19.80K -7.91% YoY	$17.00K -10.53% YoY	$15.80K -12.71% YoY	$22.50K 24.17% YoY	$21.50K 18.72% YoY	$19.00K 4.91% YoY	$18.10K -0.06% YoY	$18.12K 0.0% YoY	$18.11K 0.0% YoY	$18.11K 199.83% YoY	$18.11K N/A	$18.12K N/A	$18.11K N/A	$6.040K N/A	N/A	N/A	N/A
Operating Expenses	$6.898M 326.25% YoY	$5.657M 617.29% YoY	$3.288M -1493.14% YoY	$3.339M 500.51% YoY	$1.618M -4.59% YoY	$788.7K -50.15% YoY	-$236.0K -116.35% YoY	$555.9K -72.86% YoY	$1.696M -26.01% YoY	$1.582M -47.42% YoY	$1.444M -45.78% YoY	$2.049M -54.24% YoY	$2.292M -52.48% YoY	$3.009M 1.43% YoY	$2.663M -27.0% YoY	$4.477M 187.69% YoY	$4.824M 660.36% YoY
Operating Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	-$667.8K -140.04% YoY	$1.830M 11857.52% YoY	-$2.213M 36180.33% YoY	$388.1K -2231.25% YoY	$1.668M 14081.97% YoY	$15.30K -71.74% YoY	-$6.100K -58.48% YoY	-$18.21K 895.08% YoY	$11.76K -127.23% YoY	$54.14K 8.28% YoY	-$14.69K -444.03% YoY	-$1.830K -82.08% YoY	-$43.19K 26.69% YoY	$50.00K -49.81% YoY	$4.270K -96.26% YoY	-$10.21K -62.14% YoY	-$34.09K 4.47% YoY
Other Income/Expense, Net	N/A	-$257.9K N/A	$257.9K N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Pretax Income	-$7.565M -15352.62% YoY	-$4.086M 428.26% YoY	-$5.243M -2380.56% YoY	-$2.950M 413.88% YoY	$49.60K -102.94% YoY	-$773.4K -49.38% YoY	$229.9K -115.76% YoY	-$574.1K -72.0% YoY	-$1.684M -27.88% YoY	-$1.528M -48.4% YoY	-$1.458M -45.14% YoY	-$2.051M -54.31% YoY	-$2.335M -51.93% YoY	-$2.961M 3.28% YoY	-$2.658M -24.77% YoY	-$4.488M 183.43% YoY	-$4.858M 628.28% YoY
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Earnings	-$7.565M -15352.62% YoY	-$4.086M 428.26% YoY	-$5.243M -2380.56% YoY	-$2.950M 413.88% YoY	$49.60K -102.94% YoY	-$773.4K -49.38% YoY	$229.9K -115.76% YoY	-$574.1K -72.0% YoY	-$1.684M -27.88% YoY	-$1.528M -48.4% YoY	-$1.458M -45.14% YoY	-$2.051M -54.31% YoY	-$2.335M -51.93% YoY	-$2.961M 3.28% YoY	-$2.658M -24.77% YoY	-$4.488M 183.43% YoY	-$4.858M 628.28% YoY
Basic Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Earnings Per Share	-$0.97 -9800.0% YoY	-$0.59 243.06% YoY	-$0.74 -1595.96% YoY	-$0.42 225.47% YoY	$0.01 -102.28% YoY	-$0.17 -57.34% YoY	$0.05 -112.8% YoY	-$0.13 18.78% YoY	-$0.44 236.62% YoY	-$0.41 89.55% YoY	-$0.39 -100.0% YoY	-$0.11 -100.0% YoY	-$0.13 -100.0% YoY	-$0.21 -100.0% YoY	-$224.1K -28.19% YoY	-$378.8K 65.76% YoY	-$410.3K 308.41% YoY
COMMON SHARES	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	N/A	N/A	N/A	N/A	N/A	4.524M 1.35% YoY	N/A	N/A	N/A	4.464M -74.63% YoY	N/A	N/A	N/A	17.59M N/A	N/A	N/A	N/A
Diluted Shares Outstanding	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Loading...